|
Market Closed -
Australian S.E.
10:10:31 21/09/2026 +04
|
5-day change | 1st Jan Change | ||
| 0.3400 AUD | -1.45% |
|
-2.86% | -47.69% |
| 08-31 | Recce Pharmaceuticals Ltd Reports Earnings Results for the Full Year Ended June 30, 2026 | CI |
| 08-31 | Recce Pharmaceuticals Ltd Auditor Raises 'Going Concern' Doubt | CI |
| Market Cap | 105M 74.99M 65.39M 61.75M 56.07M 105M 7.2B 740M 285M 3.66B 282M 275M 11.77B | P/E 2027 * |
-4.06x | P/E 2028 * | 3.11x |
|---|---|---|---|---|---|
| Enterprise Value | 130M 92.74M 80.87M 76.36M 69.34M 130M 8.9B 915M 353M 4.52B 348M 341M 14.56B | EV / Sales 2027 * |
10.4x | EV / Sales 2028 * | 1.06x |
| Free-Float |
62.73% | Yield 2027 * |
-
| Yield 2028 * | - |
Australian S.E.AUD
| Markets | Quality | ||
|---|---|---|---|
Australian S.E.
| RCE | Delayed | |
Deutsche Boerse AG
| R9Q | Delayed | |
|
Börse Stuttgart
| R9Q | Delayed | |
|
Boerse Muenchen
| R9Q | Real-time | |
|
Tradegate
| R9Q | Real-time |
| 1 day | -1.45% | ||
| 1 week | -2.86% | ||
| Current month | -9.33% | ||
| 1 month | -6.85% | ||
| 3 months | -29.90% | ||
| 6 months | -29.17% | ||
| Current year | -47.69% |
| 1 week | 0.32 |  | 0.36 |
| 1 month | 0.32 | | 0.38 |
| Current year | 0.32 | | 0.73 |
| 1 year | 0.32 | | 0.73 |
| 3 years | 0.28 | | 0.73 |
| 5 years | 0.28 | | 1.38 |
| 10 years | 0.13 | | 1.88 |
| Manager | Title | Age | Since |
|---|---|---|---|
James Graham
CEO | Chief Executive Officer | - | 28/08/2020 |
Justin Reynolds
DFI | Director of Finance/CFO | - | - |
Michele Dilizia
CTO | Chief Tech/Sci/R&D Officer | - | 30/09/2020 |
| Director | Title | Age | Since |
|---|---|---|---|
Michele Dilizia
BRD | Director/Board Member | - | 01/10/2012 |
James Graham
BRD | Director/Board Member | - | 01/05/2012 |
| Director/Board Member | - | 01/09/2022 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 31/07/26 | Buy | Chief Executive Officer | 25,000 | 0.0083% | ||
| 31/07/26 | Buy | Director | 75,000 | 0.0250% | ||
| 31/07/26 | Buy | Director | 37,500 | 0.0125% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -1.45% | -2.86% | -13.92% | -26.88% | 74.99M | |
| +0.04% | +3.34% | +53.32% | +102.40% | 1,028B | |
| -0.09% | +1.66% | +53.24% | +65.73% | 651B | |
| -0.02% | +2.66% | +18.65% | +71.84% | 466B | |
| +0.18% | +3.66% | +34.59% | +39.32% | 346B | |
| +0.48% | +2.73% | +17.73% | +23.91% | 266B | |
| -0.50% | +6.76% | +10.58% | +14.16% | 259B | |
| +1.55% | +2.20% | +35.12% | +42.07% | 208B | |
| -0.74% | +1.84% | -27.55% | -57.51% | 191B | |
| -0.52% | +4.45% | +31.57% | +97.98% | 186B | |
| Average | -0.26% | +2.65% | +21.33% | +37.30% | 360.18B | |
| Weighted average by Cap. | -0.11% | +3.09% | +34.84% | +61.40% |
| 2027 * | 2028 * | |
|---|---|---|
| Net sales | 12.5M 8.88M 7.75M 7.31M 6.64M 12.44M 852M 87.61M 33.81M 433M 33.37M 32.63M 1.39B | 54.3M 38.6M 33.66M 31.78M 28.86M 54.07M 3.7B 381M 147M 1.88B 145M 142M 6.06B |
| Net income | -25.1M -17.84M -15.56M -14.69M -13.34M -24.99M -1.71B -176M -67.91M -870M -67.02M -65.54M -2.8B | 33.4M 23.74M 20.7M 19.55M 17.75M 33.26M 2.28B 234M 90.37M 1.16B 89.19M 87.21M 3.73B |
| Net Debt | 24.96M 17.75M 15.47M 14.61M 13.27M 24.86M 1.7B 175M 67.54M 866M 66.66M 65.18M 2.79B | -48.1M -34.19M -29.82M -28.15M -25.57M -47.9M -3.28B -337M -130M -1.67B -128M -126M -5.37B |
Employees
-
Sector
Pharmaceuticals
| Date | Price | Change | Volume |
|---|---|---|---|
| 21/09/26 | A$0.3400 | -1.45% | 13,655 |
| 18/09/26 | A$0.3450 | +2.99% | 25,466 |
| 17/09/26 | A$0.3350 | +1.52% | 19,844 |
| 16/09/26 | A$0.3300 | +3.13% | 69,748 |
| 15/09/26 | A$0.3200 | -8.57% | 277,844 |
Annual profits - Rate of surprise
- Stock Market
- Stocks
- RCE Stock
Select your edition
All financial news and data tailored to specific country editions
